CIK: 0001799883 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value ($000): $492,476 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | VOR BIOPHARMA INC | 6,692,429 | $104,937 | 21.3% | $43.10 | — | COM | 929033108 |
| — | RALLYBIO CORP | 4,190,724 | $73,673 | 15.0% | $17.58 | — | COM | 75120L100 |
| — | AKOUOS INC | 4,135,784 | $48,016 | 9.7% | $22.50 | — | COM | 00973J101 |
| — | HOMOLOGY MEDICINES INC | 4,535,919 | $35,698 | 7.2% | $20.70 | — | COM | 438083107 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,398,066 | $35,637 | 7.2% | $7.13 | +227.3% | COM | 45166A102 |
| — | IMPEL NEUROPHARMA INC | 2,884,791 | $35,137 | 7.1% | $8.85 | — | COM | 45258K109 |
| ARVN | ARVINAS INC | 400,000 | $32,872 | 6.7% | $29.28 | +201.9% | COM | 04335A105 |
| CABA | CABALETTA BIO INC | 2,359,263 | $28,689 | 5.8% | $11.85 | -22.2% | COM | 12674W109 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,362,286 | $28,676 | 5.8% | $19.04 | +9.9% | COM | 22663K107 |
| — | SCPHARMACEUTICALS INC | 3,831,474 | $25,479 | 5.2% | $5.92 | — | COM | 810648105 |
| RNAM | AVIDITY BIOSCIENCES INC | 555,555 | $13,683 | 2.8% | $21.74 | 0.0% | COM | 05370A108 |
| — | IVERIC BIO INC | 770,000 | $12,505 | 2.5% | $16.24 | — | COM | 46583P102 |
| JANX | JANUX THERAPEUTICS INC | 446,266 | $9,653 | 2.0% | $22.27 | +29.2% | COM | 47103J105 |
| — | 5 01 ACQUISITION CORP | 365,126 | $3,586 | 0.7% | $10.17 | — | COM CL A | 33836P105 |
| — | CIDARA THERAPEUTICS INC | 1,134,511 | $2,541 | 0.5% | $3.84 | — | COM | 171757107 |
| SPRY | SILVERBACK THERAPEUTICS INC | 169,748 | $1,694 | 0.3% | $24.66 | 0.0% | COM | 82835W108 |